Home LiteratureArticle Details
PMID: 911606 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial

Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

British journal of clinical pharmacology ·Vol. 4 ·No. 5 ·1977-10-00 ·Pages 597-603

Morrison PJ, Bradbrook ID, Rogers HJ

Abstract

1 A quantitative thin layer chromatographic technique for the estimation of plasma prednisolone levels has been devised with a minimum level of estimation of 10 ng/ml. 2 A comparative study of the absorption of 5 and 10 mg prednisolone from enteric and non-enteric coated tablets (5 mg) was carried out in healthy subjects. 3 Mean plasma half-life and peak plasma concentrations obtained from the non-enteric coated preparation agree well with previous studies in normal subjects reported by other investigators using competitive protein binding or radioimmunoassay techniques. Intersubject variability in bioavailability was noted. 4 Enteric coating increased the lag time before prednisolone appeared in the blood but did not alter the bioavailability of prednisolone compared to the equivalent dose of the non-enteric coated tablet.

MeSH Terms
Adult Biological Availability Humans Male Prednisolone/administration & dosage,blood Tablets Tablets, Enteric-Coated Time Factors
Chemicals
Tablets Tablets, Enteric-Coated Prednisolone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Morrison P J
Bradbrook I D
Rogers H J
References (12)
12 references, click to expand
  1. Prevention of peptic ulceration during corticosteroid therapy.
    Br Med J. 1959 Oct 10;2(5153):680 PMID: 13844131
  2. A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.
    Br J Clin Pharmacol. 1976 Oct;3(5):903-6 PMID: 973985
  3. Prednisolone levels in the plasma and urine: a study of two preparations in man.
    Br J Clin Pharmacol. 1975 Aug;2(4):327-32 PMID: 1233992
  4. Measurement of plasma prednisolone in man.
    Br J Clin Pharmacol. 1975 Aug;2(4):321-5 PMID: 1233991
  5. Absorption of enteric and non-enteric coated prednisolone tablets.
    Br J Clin Pharmacol. 1975 Aug;2(4):317-20 PMID: 1233990
  6. Pharmacokinetic criteria for the evaluation of retard formulations.
    Eur J Clin Pharmacol. 1974 Oct 4;7(6):429-32 PMID: 4155170
  7. Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.
    Ann Rheum Dis. 1972 Sep;31(5):379-83 PMID: 4341966
  8. Simultaneous competitive protein binding assay for cortissol, cortisone, and prednisolone in plasma, and its clinical application.
    Clin Chem. 1973 Jul;19(7):731-6 PMID: 4351361
  9. Comparative bioavailabilities from truncated blood level curves.
    J Pharm Sci. 1975 Sep;64(9):1521-4 PMID: 1185570
  10. Patterns of plasma levels of prednisolone after oral administration in man.
    J Pharmacokinet Biopharm. 1974 Apr;2(2):175-87 PMID: 4427221
  11. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects.
    J Clin Endocrinol Metab. 1974 Mar;38(3):407-12 PMID: 4815171
  12. Radioimmunoassay for prednisolone.
    Steroids. 1973 Jun;21(6):833-46 PMID: 4716628
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1977-10-00
Pages
597-603
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1429147
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]